← MHRA ALERTS
MHRA (UK) · DRUG SAFETY UPDATE30 April 2026
Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphylaxis with overuse
Alert type
Drug Safety Update
Alert date
30 April 2026
Regulator
MHRA (United Kingdom)
READ THE FULL ALERT
The complete MHRA alert — the affected products, batches, and the action required — is published on GOV.UK. SPEQ surfaces and indexes it for reference; the authoritative notice lives on gov.uk.
View on gov.uk →TURN IT INTO ACTION
Alert details are published by the UK MHRA on GOV.UK; SPEQ surfaces them for reference and is not affiliated with or endorsed by the MHRA. The authoritative notice is on gov.uk.